Authors : Helen Oroboghae Ogefere; God'sfavour Efiose John

Volume/Issue : Volume 10 - 2025, Issue 10 - October

Google Scholar : https://tinyurl.com/4hptdn3v

Scribd : https://tinyurl.com/psd4axts

DOI : https://doi.org/10.38124/ijisrt/25oct1159

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : A total of 240 Staphylococci isolates were obtained from various clinical samples. These isolates were then identified using standard bacteriological techniques including colonial morphology, Gram staining, catalase and coagulase. The detection of lnducible clindamycin resistant (ICR) Staphylococcus species was done by D-Test method. Antimicrobial susceptibility test was performed using Kirby-Bauer diffusion method. The prevalence of ICR among Staphylococcus species obtained from this study was 22 (9.17%). Isolates that had inducible resistance to clindamycin was higher in methicillin resistant S. aureus isolates 16 (80.00%) than in methicillin sensitive S. aureus isolates 4 (20.00%). Resistance to cefotaxime recorded a significantly high prevalence in S. aureus 180 (96.78), CONS 54 (100.00%) and ICR 22 (100.00%) isolates. All isolates were more sensitive to imipenem/cilastin as compared to other antibiotics tested. The good oral absorption of clindamycin makes it an alternative option for use in treatment.

References :

1. Abdullahi I. J., Rabiu I., Bawa K. I. and Abdulfatai K. (2022). Determination of Inducible Clindamycin Resistance Amongst Clinical Isolates of Methicillin-Resistant Staphylococcus aureus in Kaduna, Nigeria. Journal of Advances in Microbiology, 22(1): 32-38.
2. Ade, T. I., Osiyemi, J. A., Aso, R. E., Akinduti, P. A., and Sunmola, N. O. (2022). Prevalence of Macrolide-Lincosamide-Streptogramin-B resistance among clinical Staphylococcus aureus isolates in University of Ilorin Teaching Hospital, Ilorin, Nigeria. African Journal of Clinical and Experimental Microbiology, 23 (2): 168 - 173.
3. Afridi, F. I., Zeb, M., Hussain, A., Farooqi, B. J., and Murtuza, G. (2014). Inducible clindamycin resistance in Staphylococcus species. Journal of the College of Physicians and Surgeons, 24(7): 481–484.
4. Anand, K. B., Agrawal, P., Kumar, S., and Kapila, K. (2009). Comparison of cefoxitin disc diffusion test, oxacillin screen agar, and PCR for mecgene for detection of MRSA. Indian Journal of Medical Microbiology, 27(1): 27–29.
5. Angel, M. R, Balaji, V., Prakash, J. A. J., Brahmadathan, K. N. and Mathews M. S. (2008). Prevalence of inducible clindamycin resistance in Gram positive organisms in a tertiary care centre. Indian Journal of Medical Microbiology, 26 (3): 262-264.
6. Chika, E, Joseph, N. F. and Chijioke, E. (2018). Detection of constitutive and inducible-clindamycin-resistance in clinical isolates of Staphylococcus aureus from a Federal Teaching Hospital in Abakaliki, Nigeria. Nigerian Journal of Bacteriology and Infectious Diseases, 2(1):31–34.
7. Clinical and laboratory standards institute (2012). Performance standards for antimicrobial susceptibility testing; twenty second informational supplement. Wayne, Pennsylvania, 32(2): 34-35.
8. Clinical and laboratory standards institute (2013). Performance standards for antimicrobial susceptibility testing; twenty third informational supplement. Wayne, Pennsylvania, 33(1): 84-87.
9. Colclough, A., Corander, J., Sheppard, S. K., Bayliss, S. C. and Vos, M. (2019). Patterns of cross-resistance and collateral sensitivity between clinical antibiotics and natural antimicrobials. Evolutionary Applications, 12(5):878-887.
10. Deotale, V., Mendiratta, D.K, Raut, U. and Narang, P. (2010). Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. Indian Journal of Medical Microbiology, 28(2): 124-126.
11. Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E. and Courvalin, P. (2007). Modes and Modulations of antibiotics resistance gene expression. Clinical Microbiology Review, 20(1): 79-114.
12. Fasih, N., Irfan, S., Zafar, A., Khan, E., and Hasan, R. (2010). Inducible clindamycin resistance due to expression of erm genes in Staphylococcus aureus: report from a tertiary care Hospital Karachi, Pakistan. The Journal of the Pakistan Medical Association, 60(9): 750–753.
13. Ifediora, A. C., Nwabueze, R. N., Amadi, E. S. and Chikwendu, C. I. (2019). Methicillin and Inducible Clindamycin-resistant Staphylococcus aureus Isolates from Clinical Samples in Abia State. Microbiology Research Journal International, 29(4): 1-9.
14. Leclercq, R. (2002). Mechanisms of Resistance to Macrolides and Lincosamides: Nature of the Resistance Elements and Their Clinical Implications. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of Americas, 34(4): 482–492.
15. Li, L., Feng, W., Zhang, Z., Xue, H. and Zhao, X. (2015). Macrolide- lincosamide- Streptogramin resistance phenotypes and genotypes of coagulase-positive Staphylococcus aureus and coagulase-negative staphylococcal isolates from bovine mastitis. Biomedical Central Veterinary Research , 11(1): 168- 170.
16. Lim, H.S., Lee, H., Roh, K.H., Yum, J.H., Yong, D. and Lee, K. (2006). Prevalence of inducible clindamycin resistance in staphylococcal isolates at Korean tertiary care hospital. Yonsei Medical Journal, 47(4): 480-484.
17. Kavitha E, Srikumar R, and Muthu G. (2018). Inducible Clindamycin Resistance among Clinical Isolates from a Tertiary Care Hospital. Research Journal of Pharmacy and Technology, 11(11): 5008-5012.
18. Majhi, S., Dash, M., Mohapatra, D., Mohapatra, A., and Chayani, N. (2016). Detection of inducible and constitutive clindamycin resistance among Staphylococcus aureus isolates in a tertiary care hospital, Eastern India. Avicenna journal of medicine, 6(3), 75–80.
19. Medugu, N., Nwajiobi-Princewill, P. I., Shettima, S. A., Mohammed, M. M., Mohammed, Y., Wariso, K., Akujobi, C. N., Oduyebo, O. O. and Iregbu, K. C. (2021). A mini- national surveillance study of resistance profiles of Staphylococcus aureus isolated from clinical specimens across hospitals in Nigeria. Nigerian Journal of Clinical Practice, 24(2):225-232.
20. Naing, L., Winn, T. and Russo, B. N. (2006), Practical issues in calculating the sample size in prevalence studies: National Population Commission. Archives of Orofacial Science, 1(1): 9-14.
21. Nwokah, E. and Abbey S. D. (2016). Inducible Clindamycin Resistance in Staphylococcus aureus Isolates in Rivers State, Nigeria. American Journal of Clinical and Experimental Medicine, 4(3):50-55.
22. Ogefere, H. O. and Ogunleye, L. A. (2019). Molecular Characterization of methicillin-resistant Staphylococci among apparently healthy students. Universa Medicina, 38(1): 25-32.
23. Rahbar, M., and Hajia, M. (2007). Inducible clindamycin resistance in Staphylococcus aureus: a cross-sectional report. Pakistan Journal of Biological Sciences, 10(1): 189–192.
24. Sharma, S., Praveen, S., Devi, K. S., Sahoo, B., Singh, W. S., and Singh, T. D. (2014). Prevalence of Streptococcus pyogenes infection in children aged between 5 to 15 years with acute tonsillopharyngitis and its antibiogram. IOSR Journal of Dental and Medical Sciences, 1(13), 50–55.
25. Tenson, T., Lovmar, M., and Ehrenberg, M. (2003). The mechanism of action of macrolides, lincosamides and Streptogramin B reveals the nascent peptide exit path in the ribosome. Journal of Molecular Biology, 330(5): 1005–1014.
26. Thapa, D., Pyakurel, S., Thapa, S., Lamsal, S., Chaudhauri, M., Adhikari, N. and Shrestha, D. (2021). Staphylococcus aureus with inducible clindamycin resistance and methicillin resistance in a tertiary hospital in Nepal. Tropical Medicine and Health, 49(1): 99-105.
27. Woods, C. R. (2009). Macrolides, clindamycin, and streptogramins: Mechanisms of resistance and clinical implications. Pediatric Infectious Disease Journal, 28(10), 57–60.